Tasigna Atherosclerosis Lawsuit News

Information and News About Tasigna Atherosclerosis Lawsuits

Tasigna Patients Are Warned of The Risk of Sudden Death | 5/13/2019

Novartis has taken measures, updating their US website's homepage, to alert the public of the FDA's QT prolongation and atherosclerosis warnings...READ MORE

Tasigna's Atherosclerosis Risk Is Well-Documented By Researchers For Peer-Reviewed Medical Publications | 5/8/2019

Novartis has buried critical Tasigna atherosclerosis warnings deep in its website where it is unlikely to draw much attention...READ MORE

Tasigna's Atherosclerosis Side Effect Is Not Forgotten | 4/17/2019

Novartis is stealing headlines for Tasigna's cancer-fighting effectiveness, but the drug's atherosclerosis side effects remain as deadly as ever...READ MORE

Trying Tasigna As A Last Resort May Make Sense To Terminally Ill Cancer Patients | 4/12/2019

Tasigna carries severe severe atherosclerosis making the drug a sensible choice for only the most hopeless cancer patients...READ MORE

Novartis Claim Tasigna Can Help Parkinson's Patients is Met With Skepticism | 4/4/2019

Given the fraud and deception that Novartis has admitted to in the past, it is hard to take any medical breakthrough the company claims seriously...READ MORE

Novartis Failed To Warn American Doctors Who In Turn Failed To Warn Patients of Tasigna's Atherosclerosis Risks | 3/20/2019

Patients have a right to know if the drug they are being given is more deadly than the disease it is intended to treat and drug companies have a responsibility to inform doctors...READ MORE

Tasigna Is Being Repurposed To Treat Parkinson's Disease | 3/14/2019

Tasigna's severe side effects are a fast-fading memory as Novartis promotes Tasigna in every possible market...READ MORE

Some Patient Can Cease Taking Tasigna But They May Have Already Developed Atherosclerosis | 3/12/2019

Just because a patient is cancer-free doesn't mean that his health problems are over...READ MORE

Health Experts Warn of Potentially Deadly Tasigna Drug Interactions | 3/5/2019

Leading health professionals have reported that certain drug interactions with Tasigna can be fatal...READ MORE

The Potential To Someday Stop Tasigna Treatments Should Not Be An Incentive To Take The Drug | 2/28/2019

Billion dollar fines fail to slow Novartis' use of unethical and illegal sales tactics to sell their dangerous anti-cancer drug...READ MORE

Tasigna Studies Show The Drug Should Be Taken As A Last Resort | 2/24/2019

Tasigna is being over-promoted as a breakthrough cancer drug, encouraging its overuse...READ MORE

Cancer Doctors and Medical Websites Should Take Tasigna's Atherosclerosis Risks More Seriously | 2/18/2019

Doctors know that cancer patients have much on their minds when choosing a cancer treatment and may not think the patients can handle making a Tasigna atherosclerosis decision...READ MORE

The FDA May Be Putting Children's Lives In Danger By Ignoring Tasigna's Atherosclerosis Risk | 2/12/2019

The FDA is rolling the dice when one adds the already high rates of atherosclerosis in children given anti-cancer drugs with Tasigna's admission of being the most toxic drug of them all...READ MORE

The FDA May Have Overlooked Tasigna's Atherosclerosis Side Effect When Approving its Usage by Children | 2/5/2019

Tasigna may be a revolutionary way to treat cancer but may cause other diseases equally bad or worse...READ MORE

Children With Cancer May Now Start Taking Tasigna | 1/31/2019

The US FDA must have overlooked that Tasigna has been shown to produce irreversible atherosclerosis in an unacceptably high number of patients...READ MORE

Studies Reported by Leading Experts Focus on Tasigna Toxicity | 1/25/2019

No study of Tasigna's effects on a patient's heart health would be complete without checking to see what the world's leading authority on blood had to say...READ MORE

Novartis Has a History of Deceptive Sale Practices That Taints Their Credibility | 1/22/2019

Novartis has paid hundreds of millions of dollars in fines to the US, EU, Greece, Japan, and Korea for the fraud it has perpetrated on government health care systems around the world...READ MORE

Novartis Changes Tasigna's Label But Not Its Toxicity | 1/16/2019

Some patients can stop taking Tasigna at some point but the drug's long-term side effects such as atherosclerosis will continue...READ MORE

Tasigna Doctors May Be Ignoring Atherosclerosis Risks | 1/11/2019

Tasigna cancer patients must watch for the signs that they have started to develop atherosclerosis...READ MORE

Cancer Doctors Prescribing Tasigna Should Be Trained Like Heart Specialists | 1/8/2019

The adverse side effects of Tasigna force oncologists to test their patients for heart and blood abnormalities to avoid heart disease and at times sudden death...READ MORE

Tasigna is Effective in Treating Chronic Myeloid Leukemia | 1/1/2019

People should be aware of the symptoms of leukemia as early as possible in order to treat the disease effectively...READ MORE

Early Warning Signs of Chronic Myeloid Leukemia (CML) | 12/5/2018

The early diagnosis of CML increases the effectiveness of Tasigna chemotherapy treatments...READ MORE

CML Patients in Remission May Discontinue Taking Tasigna | 12/1/2018

Many of the adverse side effects of Tasigna chemotherapy can be avoided since for some the drug may be discontinued...READ MORE

Tasigna's Atherosclerosis Warnings is Rarely Seen by Cancer Patients | 11/28/2018

Even a black box warning can go unnoticed by patients with cancer that are fighting for their lives...READ MORE

Novartis' Failure to Warn the FDA May Have Led to Atherosclerosis in As Many As One in Four Tasigna Patients | 11/12/2018

Novartis has failed to officially warn cancer patients in the US that Tasigna can cause a disease even more deadly than cancer...READ MORE

Novartis Highlights Tasigna's Effectiveness yet Downplays The Drug's Deadly Side Effects | 11/8/2018

There is a seemingly endless list of life-threatening side effects from taking the potent, yet highly toxic anti-cancer drug Tasigna and they make a person wonder if the treatment is not even worse than the disease...READ MORE

Novartis Takes Advantage of Tasigna's Catch 22 | 10/30/2018

Only the most distressed and terminal cancer patients are given Tasigna, therefore the fact that they could develop atherosclerosis is merely an afterthought...READ MORE

Tasigna Atherosclerosis Ignored by Novartis Celebrity Spokesperson | 10/24/2018

Tasigna patients could require coronary bypass surgery...READ MORE

Oncologists May Be Ignoring the Cardiovascular Side Effects of Tasigna | 10/16/2018

Oncologists are thrilled with Tasigna's cancer-fighting results yet choose to ignore the greater risk of atherosclerosis Tasigna chemotherapy poses...READ MORE

The FDA Atherosclerosis Warning Came Too Late for Tasigna Patients in the United States | 10/8/2018

Novartis warned Canadians of the atherosclerosis health risk of Tasigna while simultaneously increasing the sales of the drug in the billion-dollar US market...READ MORE

One-Third of Tasigna Patients Could Face Coronary Bypass Surgery | 10/4/2018

Tasigna may be the strongest drug on the market in fighting cancer but the side effects make the risks greater than the benefits...READ MORE

Billion Dollar Fines Are Just a Cost of Doing Business For Novartis | 10/2/2018

Novartis has a history of devious behavior when it comes to marketing dangerous and potentially deadly drugs worldwide...READ MORE

Cancer Patients Should View Novartis' New Tasigna Label With Scepticism | 9/28/2018

Swiss pharmaceutical maker Novartis AG has a history of illegally and overzealously marketing their drugs while conveniently neglecting to mention their side effects...READ MORE

Novartis Boasts of Tasigna's Effectiveness While Ignoring the Atherosclerosis Side Effects | 9/27/2018

The old saying "if it sounds too good to be true, it probably is," applies perfectly to a recent announcement by Novartis, maker of the anti-cancer drug Tasigna...READ MORE

Tasigna May Be One Of The Most Deadly Drugs On The Market Today | 9/25/2018

According to the National Institute of Health and Novartis may well have known about it years ago...READ MORE

NBA Star's Arterial Blockage May Have Been Caused by Taking Tasigna | 9/22/2018

Kareem Abdul Jabbar was required to undergo "quadruple coronary bypass surgery" despite being a vegan and living a healthy lifestyle. His only vice might have been using the anti-cancer drug Tasigna...READ MORE

Taxpayers Saved Billions By Novartis AG Whistleblower | 9/20/2018

The False Claims Act is the leading tool for corporate insiders to come forward and report what they know to the US Department of Justice...READ MORE

Tasigna Carries The Unacceptable Risk of Developing Atherosclerosis and Amputation | 9/19/2018

There is growing evidence that Tasigna patients may be simply trading one deadly disease for another...READ MORE

Tasigna's Cancer-Fighting Success May Be Tempered By The Risk Of Sudden Death | 9/17/2018

Oncologist's enthusiasm over Tasigna's cancer-treating effectiveness may cause them to overlook the drug's deadly side effects...READ MORE

Novartis Pulled No Punches In Warning Canadians About The Atherosclerosis Related Side effects Of Tasigna Yet Said Nothing To Warn Cancer Patients In The United States. | 9/11/2018

Canadian health officials were provided an urgent warning to be aware that Tasigna can cause atherosclerosis while no such warning made its way to the US market...READ MORE

Novartis is a Repeat Offender for Fraudulent Drug Marketing | 8/29/2018

It may be just a matter of time before Novartis puts profits ahead of patient safety in marketing yet another life-threatening drug...READ MORE

Peripheral Artery Disease Plagues Tasigna Patients | 8/27/2018

Tasigna patients relieved to have beaten cancer may now be faced with a death sentence from peripheral artery disease...READ MORE

Patients Could Have Benefited From Gleevec's Generic Alternative | 8/21/2018

Not only does Tasigna ruin a person's health, it costs ten times more than Gleevec's generic competition...READ MORE

Novartis/Tasigna Lawsuit May Seek Punitive Damages | 8/17/2018

Novartis may have withheld its knowledge that Tasigna causes atherosclerosis from the FDA when seeking the drugs initial approval...READ MORE

Tasigna Atherosclerosis Trial Set to Proceed | 8/14/2018

Anti-cancer chemotherapy drugs are so toxic that the body's arteries may be incapable of handling them...READ MORE

Medical Websites Ignore Tasigna's Risks | 8/10/2018

Medical professionals are so enthusiastic about the drug's ability to fight cancer that they are ignoring Tasigna's other life-threatening side effects including sudden death...READ MORE

Novartis haste in rushing Tasigna to market has cost patients their lives | 8/8/2018

Novartis put company profits ahead of human life when they rushed Tasigna to market without properly testing it first...READ MORE

Tasigna's Side Effects Require Special Attention From Prospective Patients | 8/6/2018

When sudden death, amputation, and strokes are taken into account, few patients have been properly informed of the risks of Tasigna...READ MORE

Novartis Whistleblower Receives $12 Million For His Efforts | 7/31/2018

The False Claims Act encourages drug company employees to assists the government in policing Specialty Pharmacies...READ MORE

Tasigna Atherosclerosis Hidden From Americans | 7/30/2018

Canadians were warned about Tasigna but Americans were not...READ MORE

Gleevec Was a Cancer-Curing Miracle Drug | 7/26/2018

Novartis put profits ahead of patient safety when the rushed Tasigna to market. Cancer patients lived longer when taking Gleevec yet Novartis replaced it with Tasigna fearing a drop in corporate profits...READ MORE

Tasigna Stroke Victim's Trial to Proceed in Florida | 7/24/2018

Dennis McWilliams alleges Novartis failed to warn him of the adverse side effects of Tasigna that caused him to have a paralyzing stroke...READ MORE

Novartis Employee Blows Whistle on Tasigna Fraud and Others | 7/20/2018

The FDA forces Novartis to pay $500 million in fines for Medicaid and Medicare fraud for misrepresenting five of its patented drugs including Tasigna...READ MORE

Tasigna Side Effects Are Worse Than Cancer | 7/18/2018

At what point does a cancer patient decide that they are better off waiting to die from cancer rather than undergo Tasigna chemotherapy with all its risks?...READ MORE

Tasigna Cancer Medication Carries More Risks Than Others | 7/11/2018

As if suffering from cancer was not enough, Tasigna patients have to worry about amputations, paralysis and sudden death...READ MORE

Specialty Pharmacists Bribed to Prescribe Tasigna | 7/6/2018

Generic drug competition led to specialty pharmacists refilling Gleevec prescriptions with the more potent Tasigna...READ MORE

Novartis Billion-Dollar Fine for Fraudulent Marketing Tactics | 7/2/2018

Swiss pharmaceutical company Novartis AG was forced to pay the largest fine ever handed down under the US False Claims Act...READ MORE

Tasigna Black Box Warning Addendum | 6/29/2018

Tasigna has so many deadly side effects that an FDA Black Box warning merely scratches the surface...READ MORE

Tasigna Replaced Gleevec and Patients Suffered | 6/25/2018

Novartis replaced Gleevec with Tasigna and for many patients suffering from a rare form of leukemia, the results have been catastrophic...READ MORE

Specialty Pharmacists Selling Tasigna Compromised Ethical Standards | 6/20/2018

Novartis' Tasigna sales reps and specialty pharmacists practice the highest ethical standards so long as profits are not compromised...READ MORE

US Department of Justice Fines Novartis One Billion Dollars | 6/13/2018

Company whistleblower information reveals deceptive and illegal drug sales tactics by Novartis sales representatives...READ MORE

Tasigna Sudden Death Warning | 6/11/2018

Tasigna carries a warning of sudden death, heart attack, stroke and the potentials for amputations ...READ MORE

Tasigna Cancer Treatment Poses Scary Risks | 6/7/2018

The irreversible side effects of anti-cancer drug Tasigna are potentially worse than having cancer itself...READ MORE

Novartis Fraudulent Marketing Deception | 5/29/2018

Novartis sales reps knew Tasigna was linked to atherosclerosis...READ MORE

Tasigna Atherosclerosis Warning Never Made it to the US | 5/25/2018

Novartis may have put profits ahead of public safety when they failed to warn cancer patients in the US like they did in Canada and elsewhere...READ MORE

Novartis Tasigna Anti-Cancer Drug Has Side Effects That Include Sudden Death | 5/22/2018

Novartis salespeople used illegal marketing tactics to hide the deadly side effects of Tasigna that may have cost hundreds of people their lives...READ MORE

Tasigna Replaced Gleevec Under Fraudulent Circumstance | 5/18/2018

It seems as though a drug company will do anything to protect billions of dollars in profits, and view lawsuits as just another cost of doing business...READ MORE

Novartis Held Accountable For Concealing Tasigna Atherosclerosis Risk | 5/15/2018

The deceptive practices of Novartis AG have not escaped government regulators in the United States...READ MORE

Tasigna Chemotherapy Carries a Sudden Death Warning | 5/10/2018

Tasigna doctors must perform a battery of specialized tests on their cancer patients, pre-screening them for existing heart disease and blood abnormalities...READ MORE

Novartis Warns That Tasigna Can Cause Atherosclerosis | 5/6/2018

Sudden death from a heart attack is one of the many side effects of taking Tasigna anti-cancer chemotherapy...READ MORE

Tasigna Poses Atherosclerosis Amputations Risk | 5/3/2018

Anti-cancer chemotherapy drug Tasigna is causing Atherosclerosis and patients often require amputation to treat the disease...READ MORE

Tasigna Rushed to Market to Replace Gleevec | 12/29/2017

The FDA did not require the same testing of Tasigna as it would have if it had been manufactured by a different company...READ MORE

Whistleblower Saves American Taxpayers Millions | 12/22/2017

The False Claims Act encourages drug company employees to report illegal activities and can save taxpayers millions in fraudulent Medicaid and Medicare costs...READ MORE

Gleevec-the Novartis AG Wonder Drug | 12/20/2017

Life-extending cancer chemotherapy drug Gleevec went off patent in July 2015 and Tasigna rushed to market...READ MORE

Tasigna Warnings | 12/18/2017

Research institutes, government health agencies and patients around the globe warn of the link between Tasigna and vascular disease...READ MORE

Tasignas Black Box Warning Links The Drug To Atherosclerosis | 12/15/2017

Patients taking Tasigna should be constantly aware of the drug's potential to cause atherosclerosis and to watch for the signs they are developing the disease...READ MORE

Novartis Fails To Warn The U.S. Medical Community About The Side Effects of Tasigna | 12/11/2017

It is well-documented that Swiss pharmaceutical company Novartis AG knew that Tasigna caused atherosclerosis and deliberately kept the information from the American medical community...READ MORE

Tasigna Replaces Gleevec as the Novartis AGs Signature Anti-Cancer Chemotherapy Drug | 12/6/2017

Novartis AG marketed Tasigna to specialty pharmacies in the US without advising them of the Canadian health warnings...READ MORE

The Unmistakable Signs of Peripheral Artery Disease | 12/1/2017

Cancer doctors closely monitor their Tasigna chemotherapy patients for the signs that they may have PAD...READ MORE

Whistleblower Causes Public Alert to Tasigna Side Effects | 11/27/2017

Whistleblowers are encouraged to come forward when corporate activities put public health in danger...READ MORE

The Estate of a California Man is Suing Novartis | 11/20/2017

The surviving family members allege in court that Novartis knew of the atherosclerosis risks Tasigna posed and failed to warn them...READ MORE

Ex-Novartis Salesmanager Blows The Whistle On Illegal Drug Marketing | 11/13/2017

Whistleblower lawsuit against Novartis helps to shed light on the lengths drug companies go to sell their product...READ MORE

U.S. Cancer Patients Receive Tasigna Atherosclerosis Warning | 11/6/2017

Tasigna maker warns that the drug can have serious life-threatening side effects...READ MORE

Novartis Marketed Tasigna to Replace Gleevec | 11/3/2017

Economics may be the reason Tasigna was brought to market to replace Gleevec...READ MORE

Leukemia Patients May Suffer From Heart Disease as Well | 10/30/2017

Tasigna anti-cancer chemotherapy has the deadly side effect of causing atherosclerosis, a hardening, and thickening of major arteries leading to the extremities, heart and brain. ...READ MORE

Novartis' Potentially Misleading Drug Marketing Campaign | 10/23/2017

Novartis may have misled American cancer doctors and the general public when it brought Tasigna to the market...READ MORE

Health Canada Issued a Tasigna Health Warning In 2013 | 10/16/2017

Canadian health officials warn of life-threatening side effects of anti-cancer chemotherapy drug Tasigna, telling doctors in Canada to take precautions before, during, and after giving patients the drug...READ MORE

Lawsuits Allege Novartis Was Aware of The Side Effects of Tasigna Yet Failed to Warn The American Public | 10/9/2017

A California lawsuit alleges Novartis AG was aware that Tasigna could be linked to atherosclerosis and related diseases years before the American public was so informed...READ MORE

Tasigna Chemotherapy Atherosclerosis-related Side Effects | 10/2/2017

Cancer patients given Tasigna should be on the lookout for the symptoms of atherosclerosis...READ MORE

The Onder Law Firm Seeks to Hold Novartis Accountable for the Suffering Tasigna Has Caused Families | 9/29/2017

Onder Law's compassionate, zealous and experienced personal injury and wrongful death attorneys helping those who have been injured by corporate negligence and greed...READ MORE

Novartis Fails to Warn About Tasigna Atherosclerosis | 9/22/2017

Novartis neglected its responsibility to warn the American public that Tasigna may cause atherosclerosis...READ MORE

Side Effects of Tasigna Cancer Drug Include Atherosclerosis and Peripheral Artery Disease | 9/15/2017

Physical signs to look for it you suspect you have developed atherosclerosis or peripheral arterial disease...READ MORE

Novartis Put Profits Ahead of Patients | 9/7/2017

Novartis AG Failed to Warn America that Tasigna causes heart disease...READ MORE

Novartis Failed to Warn the American Medical Community of the Side Effects of Tasigna | 9/1/2017

Tasigna has been found to cause atherosclerosis and peripheral artery disease in cancer patients being treated with the deadly anti-cancer chemotherapy drug...READ MORE

Atherosclerosis Linked to Tasigna Anti Cancer Drug | 8/18/2017

Tasigna makers Novartis International AG an Anti Cancer Treatment Drug Failed to Give Side Effects Warning to Doctors and Patients ...READ MORE

You Can Sue Novartis If You Have Developed Atherosclerosis-Related Conditions After Taking Tasigna | 8/11/2017

Innocent people have been the victim of Novartis failing to warn American doctors of the extended risks of using the anti-cancer chemotherapy drug Tasigna...READ MORE

Who Can Be Considered A Tasigna Victim | 8/4/2017

Thousands of Americans may be able to file an individual lawsuit against Novartis, maker of the deadly anti-cancer drug Tasigna...READ MORE

Novartis AG makers of Tasigna Failed to Warn Public of the Dangerous Side Effects | 7/14/2017

Tasigna a drug used to treat advanced cancer patients and the makers Novartis AG under fire in a St Louis court of law...READ MORE

Tasigna Anti Cancer Drug Lawsuit | 7/7/2017

The chemotherapy drug Tasigna is used to treat cancer patients in their advanced stages but Novartis AG failed to warn consumers of proven dangerous side effects...READ MORE

Tasigna Drug Warning for Peripheral Arterial Disease | 6/30/2017

Leukemia studies show that the anti-cancer drug Tasigna indicate adverse side effects reactions in treated patients ...READ MORE

Tasigna Cancer Treatment Drug Lawsuit | 6/26/2017

Anti-cancer drug Tasigna patients experience adverse side effects without warning from the makers of the drug...READ MORE

Novartis International AG Lawsuits | 6/23/2017

The makers of Tasigna known as Novartis International AG falsely promoted the drug's effectiveness to cancer doctors ...READ MORE

Lawsuits Against Novartis International AG Makers of Tasigna | 6/21/2017

Multi-billion-dollar Tasigna anti-cancer lawsuit against swiss pharmaceutical giant Novartis International AG...READ MORE

Tasigna Peripheral Artery Disease Warning | 6/19/2017

Healthcare professionals and their patients have been misled by Tasigna anti-cancer drug makers Novartis International AG ...READ MORE

Tasigna Lawsuits Against Drug Makers Novartis | 6/16/2017

The makers Novartis of Tasigna leukemia drug continue to make a huge profit from sales regardless of the link between Tasigna and atherosclerosis caused by the use of the drug...READ MORE

Atherosclerosis of the Aorta Linked to Tasigna Anti-Cancer Drug | 6/12/2017

Tasigna anti-cancer drug is proven to have severe side effects as deadly as the disease it was marketed to treat...READ MORE

Makers of Tasigna Leukemia Drug Lawsuit | 6/9/2017

Novartis AG makers of Tasigna leukemia drug failed to warn US doctors and patients of the potential to develop atherosclerosis...READ MORE

Tasigna a Cancer Drug Treatment | 6/5/2017

Plaque buildup in the arterial walls is one of the symptoms of atherosclerosis treated by Tasigna ...READ MORE

Tasigna Peripheral Arterial Disease | 6/1/2017

Advanced peripheral arterial disease cause from Tasigna side effects include sores and lesions on the feet that do not heal normally...READ MORE

No-Cost, No-Obligation Tasigna Lawsuit Case Review If You or a Loved One Suffered from Tasigna Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.